Comcast Corporation vs Cytokinetics Inc — how do they compare? Comcast Corporation trades at $25.63 (market cap $89.43B), while Cytokinetics Inc trades at $76.66 (market cap $10.78B). The key difference: Comcast Corporation is far larger — about 8.3× Cytokinetics Inc's market cap, and Comcast Corporation pays a 5.24% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CMCSA | CYTK | |
|---|---|---|
Market Cap | $89.43B | $10.78B |
Sector | Media | Technology |
52-Week High | $32.50 | $87.26 |
52-Week Low | $21.92 | $34.31 |
Enterprise Value | $172.15B | $10.88B |
Dividend Yield | 5.24% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
Trailing returns across standard periods
Latest headlines on both assets
Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to roughly 61 million U.S. homes and businesses, or nearly half of the country. About 56% of the homes in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC broadcast network, several local NBC affiliates, Universal Studios, and several theme parks. Sky, acquired in 2018, is the dominant television provider in the U.K. and has invested heavily in exclusive and proprietary content to build this position. The firm is also the largest pay-television provider in Italy and has a presence in Germany and Austria.
Read more on CMCSA →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →